Get the Stockscreener App
2.16
2.26%
-0.05
After Hours:
2.16
Intelligent Bio Solutions Inc stock is traded at $2.16, with a volume of 13,074.
It is down -2.26% in the last 24 hours and down -8.09% over the past month.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
See More
Previous Close:
$2.21
Open:
$2.15
24h Volume:
13,074
Relative Volume:
0.13
Market Cap:
$5.17M
Revenue:
$3.91M
Net Income/Loss:
$-11.65M
P/E Ratio:
-0.1753
EPS:
-12.3212
Net Cash Flow:
$-11.51M
1W Performance:
-3.57%
1M Performance:
-8.09%
6M Performance:
-87.95%
1Y Performance:
-88.20%
1-Day Range:
$2.11
$2.22
1-Week Range:
$2.11
$2.32
52-Week Range:
$2.08
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
Name
Intelligent Bio Solutions Inc
Sector
Industry
Phone
646-790-5756
Address
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
2.16 | 5.17M | 3.91M | -11.65M | -11.51M | -12.32 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Intelligent Bio Solutions Inc Stock (INBS) Latest News
Best United Kingdom Healthcare Stocks to Watch for July 2026 - Kalkine Media
Pi3g Stocks NVIDIA DGX Station And Publishes Pricing. - openPR.com
Intelligent Bio Solutions(INBS) Stock Options Chain | Quotes & News - Moomoo
INBSIntelligent Bio Solutions Inc Revenue Breakdown - Finviz
INBS Forecast — Price Target — Prediction for 2027 - TradingView
12Q Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of Intelligent Bio Solutions Inc. – NASDAQ:INBS - TradingView
Enterprise value to EBIT forward of Intelligent Bio Solutions Inc. – NASDAQ:INBS - TradingView
Intelligent Bio Solutions Inc. Actuals & Estimates (NASDAQ:INBS) - TradingView
Intelligent Bio Solutions Inc (INBS) Valuation: PE, PB & Fair Value Analysis - TradingKey
INBS Stock Reverses Early Gains After First Shipment of Drug Screening Readers Under Syrma Johari MedTech Partnership - Stocktwits
INBS Q1 2025 Earnings: Widened Loss Exceeds Expectations as Stock DeclinesEarnings Trend Analysis - dars.gov.et
Parker-Hannifin (PH) Holds Near Support Amid Modest RetreatHigh Dividend Factor - dars.gov.et
Intelligent Bio Solutions Inc (INBS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Intelligent Bio Solutions Inc (INBS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Oncotelic Launches AI-Powered GMP Manufacturing Services Platform at BIO International Convention 2026 - GlobeNewswire
Intelligent Bio Solutions Inc (INBS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Intelligent Bio Solutions Inc (INBS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Intelligent Bio Solutions Inc (INBS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Intelligent Bio Solutions Inc (INBS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Intelligent Bio Solutions Inc (INBS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Intelligent Bio Solutions Advances Codeine Drug Test Studies - TipRanks
Intelligent Bio Solutions launches interference study to support FDA 510(k) for codeine detection - TradingView
Interference study backs Intelligent Bio (NASDAQ: INBS) U.S. codeine test - Stock Titan
Intelligent Bio Solutions starts interference study for FDA submission By Investing.com - Investing.com South Africa
Intelligent Bio Solutions starts interference study for FDA submission - Investing.com
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry - TradingView
Intelligent Bio Solutions Initiates Interference Study to Support FDA 510(k) Submission for Drug Screening System - Quiver Quantitative
Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance and Planned U.S. Market Entry - The Globe and Mail
INBS Q1 2025 Earnings: Wider-Than-Expected Loss Highlights Cost PressuresEPS Surprise History - dars.gov.et
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Share Price, INBS Stock News, INBS Share Price & Updates - Kalkine
Intelligent Bio Solutions Inc. Financial Disclosures & SEC Filings - TradingView
INBS Q1 2025 Earnings: EPS Misses Estimates as Company Reports No RevenueProduct Revenue Analysis - newsline.com
INBS Q1 2025 Earnings: Earnings Miss Widens as Losses DeepenDividend Cut Risk - newsline.com
Intelligent Bio Solutions (INBS) Holds Near Support Amid Quiet Trading SessionMACD Signal Stocks - newsline.com
Intelligent Bio Solutions (INBS) Holds Steady Near Key Support After Modest PullbackGamma Exposure - newsline.com
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference Over June 16-18 - 富途牛牛
Intelligent Bio Solutions to Participate in Planet MicroCap Las Vegas Conference over June 16-18 - marketscreener.com
Vegas microcap conference adds Intelligent Bio Solutions to lineup - Stock Titan
Intelligent Bio Solutions (INBS) Launches Study for Drug Screeni - GuruFocus
Intelligent Bio Solutions Launches Multi-Site Study for FDA 510(k) Clearance of Fingerprint Drug Screening System 1 - Minichart
Intelligent Bio Solutions Launches FDA Study for Codeine Test - TipRanks
Intelligent Bio Solutions starts FDA study for fingerprint drug test - Investing.com
Intelligent begins multi-site study to support FDA 510(k) for codeine screening - TradingView
Intelligent Bio Solutions (NASDAQ: INBS) launches multi-site 510(k) codeine drug screening study - Stock Titan
Intelligent Bio Solutions Commences Multi-Site Method Comparison Study for FDA 510(k) Submission - The Manila Times
Fingerprint drug test put in workers' hands in new U.S. study - Stock Titan
Intelligent Bio Solutions (INBS) Edges Higher: Testing Key Resistance at $2.70Fundamental Weighted - newsline.com
INBS Q1 2025 Earnings: EPS Misses Estimates Significantly, Revenue Not Reported, Stock Rises 2.19%Earnings Weakness Phase - The Legal Advocate
SNCY Q1 2026 Earnings: EPS Miss Weighs on Market Sentiment as Revenue Figures Remain Undisclosed - dars.gov.et
INBS Q1 2025 Earnings: Wider-Than-Expected Loss as Revenue Remains AbsentShort-Term Outlook - newsline.com
Intelligent Bio Solutions Inc Stock (INBS) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):